Evidence map›Paper›PMID 29518027›Full record

ArticleInternational journal of molecular sciences2018

Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.

Satoshi Inoue, Hiroki Ide, Kazutoshi Fujita, Taichi Mizushima, Guiyang Jiang, Takashi Kawahara, Seiji Yamaguchi, Hiroaki Fushimi, Norio Nonomura, Hiroshi Miyamoto

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Sex Hormone Receptor Signals in Human Malignancies.International journal of molecular sciences · 2019
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Satoshi InoueDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. inosts411@gmail.com.
Hiroki IdeDepartment of Pathology and James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. h-ide@fc4.so-net.ne.jp.
Kazutoshi FujitaDepartment of Urology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan. fujita@uro.med.osaka-u.ac.jp.
Taichi MizushimaDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. mizu123shima@gmail.com.
Guiyang JiangDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. guiyang_jiang@urmc.rochester.edu.
Takashi KawaharaDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. takashi_tk2001@yahoo.co.jp.
Seiji YamaguchiDepartment of Urology, Osaka General Medical Center, Osaka 558-8558, Japan. yamabu1956@gmail.com.
Hiroaki FushimiDepartment of Pathology, Osaka General Medical Center, Osaka 558-8558, Japan. hiroaki-fushimi@gh.opho.jp.
Norio NonomuraDepartment of Urology, Osaka University Graduate School of Medicine, Suita 565-0871, Japan. nono@uro.med.osaka-u.ac.jp.
Hiroshi MiyamotoDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA. hiroshi_miyamoto@urmc.rochester.edu.ORCID 0000-0001-7610-7769
Johns Hopkins University · USOsaka Prefectural Medical Center · JPThe University of Osaka · JPUniversity of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using preclinical models, we have recently found that ELK1, a transcriptional factor that activates downstream targets, including

Indexed as

AgedBiomarkers, TumorCarcinomaets-Domain Protein Elk-1FemaleHumansMaleMiddle AgedPhosphorylationProtein Processing, Post-TranslationalProto-Oncogene MasUrinary Bladder NeoplasmsUrotheliumBiomarkers, TumorELK1 protein, humanets-Domain Protein Elk-1MAS1 protein, humanProto-Oncogene Masandrogen receptorELK1immunohistochemistryprognosisupper urinary tract urothelial carcinoma

Identifiers

PMID29518027
PMCPMC5877638
OpenAlexW2790762202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.